Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial
Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a maintenance update to the study record display.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision tag v3.5.3 was added to the study record history, indicating a minor update to the page. The previous v3.5.2 tag was removed as part of this update.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page revision tag was updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check103 days agoChange DetectedSite update adds Revision: v3.4.2 and removes the government funding status notice (Revision: v3.4.1).SummaryDifference0.4%

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.